MDW as a Novel Diagnostic Biomarker in LONS Among Preterm Neonates
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Jul 2026
- Expected to end
- 30 Jul 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- MDW measurement
- Record updated
- 15 September 2026
Who can take part
- Age
- 73 hours to 28 days
- Sex
- Women and men
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Preterm neonates with gestational age <37 weeks
- Neonates aged >72 hours of life at the time of enrollment
- Neonates with clinical suspicion of late-onset neonatal sepsis, defined by the presence of one or more of the following:; Temperature instability (core temperature >38°C or <36°C); Respiratory distress or new-onset apnea; Feeding intolerance or poor feeding; Lethargy or irritability; Bradycardia or tachycardia; Hypotension; Unexplained clinical deterioration
Who cannot take part
- Neonates with any of the following will be excluded from the study:; Early onset neonatal sepsis; Major congenital anomalies; Chromosomal abnormalities; Metabolic disorders; Severe perinatal asphyxia; Neonates with surgical conditions
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the diagnostic accuracy of monocyte distribution width (MDW) as a novel biomarker for late-onset neonatal sepsis in preterm neonates and to assess its association with disease severity and short-term clinical outcomes
The 2 groups in the trial
- Sepsis group
This group will include 30 preterm neonates with suspected LONS who fulfill the predefined clinical and laboratory criteria of clinical sepsis and/or have positive blood culture
Treatment: MDW measurement
- Control group
It will include 30 neonates evaluated for suspected sepsis who will have negative blood cultures, will not fulfill the predefined clinical sepsis criteria, and will have an alternative non-infectious diagnosis.
Treatment: MDW measurement
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Monocyte Distribution Width as a Novel Diagnostic Biomarker in Late-Onset Sepsis Among Preterm Neonates
- Record updated
- 15 September 2026